Full Text View
Tabular View
No Study Results Posted
Related Studies
The SOURT OUT IV TRIAL (SORT OUT IV)
This study is currently recruiting participants.
Study NCT00552877   Information provided by Odense University Hospital
First Received: October 31, 2007   Last Updated: November 1, 2007   History of Changes
This Tabular View shows the required WHO registration data elements as marked by

October 31, 2007
November 1, 2007
August 2007
SAFETY (cardiac death, myocardial infarction and/or stent thrombosis) EFFICACY (target vessel revascularization) [ Time Frame: 9 months, 1 year, 2 years, 3 years ]
Same as current
Complete list of historical versions of study NCT00552877 on ClinicalTrials.gov Archive Site
 
 
 
The SOURT OUT IV TRIAL
Randomized Clinical Comparison of the Xience V and the Cypher Coronary Stents in Non-Selected Patients With Coronary Heart Disease

In a randomized study the Xience V coroary artery stent may be non inferior to the Cypher Select+ coronary stents in the treatment of unselected patients with coronary artery disease.

2 Purpose In a randomized study to compare the Cypher Select+ and the Xience V coronary stents in the treatment of unselected patients with coronary artery disease.

2.1 Primary objective In a randomized study to compare the Xience V and the Cypher Select+ coronary stents by assessing SAFETY (cardiac death, myocardial infarction and/or stent thrombosis) and EFFICACY (target vessel revascularization) after 9 months.

2.2 Secondary objective To compare device success rate, procedure success rate and complication rate during hospitalization, after 1 month and after 9 months and the incidence of late stent thrombosis after 12, 24 and 36 months.

 
Interventional
Treatment, Randomized, Single Blind (Outcomes Assessor), Active Control, Single Group Assignment, Safety/Efficacy Study
  • Ischemic Heart Disease
  • Coronary Atherosclerosis
  • Percutaneous Coronary Intervention
Device: Percutaneous coronary intervention (Xience V stent)
  • Active Comparator: Cypher Select plus stent
  • Active Comparator: Xience V stent
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Recruiting
2678
November 2008
 

Inclusion Criteria:

  • All patients treated with one or more drug eluting stents in the coronary arteries at one of the 5 heart centres in Denmark (Gentofte, Rigshospitalet, Odense, Skejby, Aalborg) can be included in the study.

Exclusion Criteria:

  • The patient will not participate
  • The patient participates in other randomised stent studies
  • Expected survival < 1 year
  • Allergy to Aspirin, Clopidogrel or Ticlopidine
  • Allergy to Sirolimus or ABT-578
Both
18 Years and older
No
Contact: Per Thayssen, MD DMSci 004565412681 per.thayssen@ouh.regionsyddanmark.dk
Contact: Lisette Okkels Jensen, MD PhD 004565412690 okkels@dadlnet.dk
Denmark
 
 
NCT00552877
 
 
Odense University Hospital
 
Principal Investigator: Per Thayssen, MD DMSci Odense University Hospital, Dept. of Cardiology
Odense University Hospital
October 2007

 †    Required WHO trial registration data element.
††   WHO trial registration data element that is required only if it exists.